SecBot SecBot
3 ·Filed Aug 12, 2026

ERAS

Erasca, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001193125-26-346920
Form 3, initial insider ownership statement
Actionable Insight • Neutral

This is a routine insider onboarding filing with no trading signal. Monitor future Form 4 filings for any open-market purchases or sales by Fuchs, which would provide actionable insider sentiment.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$17.86
T+0 close · Aug 12, 2026 · via day close
Latest settled
−19.32%
T+60 · $14.41
Vs SPY
−13.84%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 13 $17.86entry
  2. T+1 · 3mo ago +2.91%α +3.11% · $18.38
  3. T+5 · 3mo ago −4.37%α −2.40% · $17.08
  4. T+20 · 2mo ago −11.09%α −9.34% · $15.88
  5. T+60 · 11d ago −19.32%α −13.84% · $14.41
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Charles S. Fuchs, President of R&D at Erasca, filed a Form 3 initial statement of beneficial ownership, indicating he became a reporting insider. This is a routine administrative filing with no trading activity or financial details disclosed, and carries no material stock-moving implications.

Key Facts

  • Charles S. Fuchs filed a Form 3 initial statement of beneficial ownership on 2026-08-10.
  • Fuchs serves as President, R&D at Erasca, Inc.
  • The filing is a standard SEC requirement for new insiders and contains no trading or financial data.

Financial Impact

No financial impact, filing contains no monetary figures or transaction details.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001193125-26-346920
Document: 0001193125-26-346920-index.html0001193125-26-346920
Document: 0001193125-26-346920.txt0001193125-26-346920

Track record

26 reports on ERAS

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +95.35% at T+60 after the Apr 27, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $15.21 Now $15.11 −0.66% settles Feb 12
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.31 Now $15.11 −1.31% settles Feb 12
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $15.35 Now $15.11 −1.56% settles Feb 12
  4. Nov 12, 20264d ago Press Release Neutral 4/10 Entry $15.66 Now $15.11 −3.51% settles Feb 11
  5. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $14.64 Now $15.11 +3.21% settles Feb 1
  6. Oct 16, 20264w ago 8-K Neutral 2/10 Entry $13.39 Now $15.11 +12.85% settles Jan 13
  7. Aug 24, 202612w ago 8-K Bullish 5/10 Entry $17.60 Now $15.11 −14.15% settles Nov 17
  8. Aug 17, 202613w ago 144 Neutral 3/10 Entry $18.28 to $15.61 Now $15.11 −17.34% ▼ −14.61% −11.84% vs SPY
  9. Aug 13, 202613w ago Institutional Cluster Bullish 6/10 Entry $17.86 to $14.41 Now $15.11 −15.40% ▼ −19.32% −13.84% vs SPY
  10. Aug 12, 202613w ago 3 Neutral 2/10 Viewing Entry $17.86 to $14.41 Now $15.11 −15.40% ▼ −19.32% −13.84% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens in 9h 30m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 12, 2026